# A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder

> **NCT00512616** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Mental Health (NIMH)**

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Ceftriaxone

## Key facts

- **NCT ID:** NCT00512616
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-08-01
- **Primary completion:** 2009-09-15
- **Final completion:** 2009-09-15
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00512616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00512616, "A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00512616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*